Protease variants for pharmaceutical use

Details for Australian Patent Application No. 2008333313 (hide)

Owner Novozymes A/S Solvay Pharmaceuticals, GmbH

Inventors Gregory, Peter Colin; Svendsen, Allan; Kjaer, Tanja Maria Rosenkilde; Beier, Lars; Larsen, Signe Eskildsen; Lenhard, Thomas

Agent Shelston IP

Pub. Number AU-A-2008333313

PCT Pub. Number WO2009/071550

Priority 07122243.4 04.12.07 EP

Filing date 2 December 2008

Wipo publication date 11 June 2009

International Classifications

C12N 9/52 (2006.01) Enzymes, e.g. ligases (6.) - derived from bacteria

A61K 38/48 (2006.01) Medicinal preparations containing peptides

C12N 15/57 (2006.01) Mutation or genetic engineering - acting on peptide bonds (3.4)

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/071550 Priority application(s): WO2009/071550

2 February 2012 Assignment before Grant

  Novozymes A/S; Solvay Pharmaceuticals, GmbH The application has been assigned to Novozymes A/S

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008333319-Process for producing coloured polypropylene composition having a high content of beta-modification

2008333301-Method and apparatus for cooling and/ or liquefying a hydrocarbon stream